Federal Supply Schedule 36F79724D0158
- This federal contract IDV is a Federal Supply Schedule (FSS) awarded by the Department of Veterans Affairs (VA) to Kamada Inc., a foreign-owned for-profit organization. The contract is for DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS under FSS Schedule 65 I B, with a ceiling value of $25,000.00 and a period of performance from January 16, 2024 to July 14, 2024. The contract is a multiple award vehicle, meaning it allows for the placement of task orders against the schedule by...
- This Federal Supply Schedule contract, awarded on September 1, 2016, to R-Pharm US LLC (UEI: DCS8XNM7NMW7) through a multiple-award vehicle, establishes a framework for the procurement of pharmaceuticals, drugs, and hematology-related products under General Services Administration Schedule 61-IB (Pharmaceuticals and Drugs). The contract is funded by the Veterans Integrated Service Network 12, a civilian agency component of the Department of Veterans Affairs responsible for healthcare delivery to...
- This Federal Supply Schedule contract awards pharmaceutical and hematology-related products to Agios Pharmaceuticals, Inc. under GSA's Pharmaceuticals and Drugs schedule (FSS-61-IB). The contract, awarded on September 29, 2025, establishes a multiple-award indefinite delivery vehicle with a ceiling value of $225,000 and a performance period extending through September 28, 2030. The Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs, serves as...
- Thea Pharma, Inc. (UEI: KD52SC8KRMW5) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) effective February 1, 2023, with an ultimate completion date of January 31, 2028. The contract, valued at $500,000, was awarded without a set-aside restriction and supports the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract covers the procurement of drugs, pharmaceuticals,...
- Medicure Pharma Inc. (UEI: KC1ZK4GF2SX9) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on September 29, 2023, with a contract ceiling value of $7.45 million and an ultimate completion date of September 28, 2028. This civilian contract, funded by the Veterans Integrated Service Network 12 (VISN 12), was issued without a set-aside restriction and falls under Federal Acquisition Regulation category 65 I B, encompassing...
- Provepharm Inc. (UEI: RQC5M6BKFYK8) was awarded a Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. This multiple award indefinite delivery vehicle, established on March 15, 2023, carries a ceiling value of $225,000 and extends through March 14, 2028. The contract encompasses the supply of drugs, pharmaceuticals, and hematology-related products...
- Aprecia Pharmaceuticals Company, a child entity of Aprecia Pharmaceuticals, LLC, was awarded a Multiple Award Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) by the Veterans Integrated Service Network 12, a civilian agency component of the Department of Veterans Affairs. The contract, which carries a ceiling value of $9,000,000.00 and a completion date of February 28, 2027, represents a short-term extension of the existing supply agreement. The...
- Pharmaessentia USA Corp was awarded a Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on June 1, 2022, to supply drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. This multiple award contract carries a ceiling value of $6,000,000 and extends through May 31, 2027. The contract represents an administrative change to an existing agreement and...
- This Federal Supply Schedule contract awards multiple vendors, including Zydus Pharmaceuticals (USA) Inc. (UEI: QMFQCPLJ9F36), to supply pharmaceuticals, drugs, and hematology-related products under General Services Administration (GSA) schedule 61-IB. The contract was awarded on August 15, 2021, with an ultimate completion date of August 14, 2026, establishing a five-year contract period. The contract ceiling value is $9,030,680.00, with no small business set-asides applied. The Veterans...
- This Federal Supply Schedule contract awards multiple indefinite delivery vehicle positions to Aadi Bioscience, Inc. (UEI: FUGDEGHGZ583) under the General Services Administration's Pharmaceuticals and Drugs schedule (FSS-61-IB), specifically under Federal Supply Classification 65 I B for drugs, pharmaceuticals, and hematology-related products. The contract was awarded on August 1, 2022, with an ultimate completion date of July 31, 2027, establishing a five-year period of performance. The...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79724D0158Federal Supply Schedule
- Blanket Purchase Agreements
This Federal Supply Schedule contract awards a multiple award Indefinite Delivery Vehicle to Kamada Inc. (UEI: RHMCCBAFTZ95) for the supply of drugs, pharmaceuticals, and hematology-related products under General Services Administration Schedule 61-IB (Pharmaceuticals and Drugs). The contract was awarded on July 1, 2024, with an ultimate completion date of June 30, 2029, establishing a five-year period of performance. The contract carries a ceiling value of $750,000.00 and is funded by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. No set-aside was utilized for this procurement, allowing the award to be competed among all eligible vendors meeting the contract requirements. The contract scope encompasses the provision of pharmaceutical products and hematology-related supplies through the GSA Federal Supply Schedule mechanism, which enables the Department of Veterans Affairs to procure these items at pre-negotiated prices for distribution to veteran populations served by Veterans Integrated Service Network 12. The contract includes provisions for price updates in accordance with Public Law 102-585 during the 2026 performance year, ensuring pricing remains current and compliant with statutory requirements. As a multiple award schedule contract, this vehicle allows ordering offices within the Veterans Health Administration to place orders for qualified pharmaceutical products and hematology supplies from Kamada Inc. throughout the contract period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Supplemental Agreement for work within scope | $0 | 12/14/25 | |
| P00004 | Supplemental Agreement for work within scope | $0 | 10/27/25 | |
| P00003 | Supplemental Agreement for work within scope | $0 | 10/8/25 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 12/10/24 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 11/27/24 |